Oxibutinina Eg (Oxybutynin Hydrochloride)

Oxybutynin hydrochloride, the active ingredient in Oxibutinina Eg, is an antispasmodic presented as a tablet for oral use. It treats overactive bladder symptoms such as urgency, frequency and urge incontinence in adults. GNH USA supplies Oxibutinina Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Oxibutinina Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxibutinina Eg is an antimuscarinic agent that acts on the urinary bladder smooth muscle to reduce involuntary contractions.

- Overactive bladder: helps relieve urgency, frequency and urge incontinence. - Neurogenic bladder dysfunction: improves bladder storage capacity in patients with neurological conditions. - Detrusor overactivity: decreases involuntary detrusor contractions during the filling phase.

Side effects of oxy‑butyl‑like drugs are reported across a range of frequencies.

Common Side Effects: - Dry mouth - Constipation - Blurred vision - Drowsiness - Urinary retention - Headache

Serious or Rare Side Effects: - Severe allergic reactions (anaphylaxis) - Tachycardia or arrhythmias - Acute urinary retention requiring catheterisation - Hallucinations or confusion - Elevated intra‑ocular pressure causing glaucoma - Liver enzyme abnormalities

When using Ox​  ​     ​  ​   ​    …  … … … ...  ... … … … … … … … … … … … … … 

-    …   … …  … … ... ... … … … … ... … … … … … … … ... … …  -  … … … … ... … ... … … … … … … … … … … … … … … … ...